运用健康信念模型探究沙特阿拉伯血液透析患者对新冠病毒加强疫苗的接种犹豫:一项多中心经验
COVID-19 Booster Vaccine Hesitancy among Hemodialysis Patients in Saudi Arabia Using the Health Belief Model: A Multi-Centre Experience.
作者信息
Alobaidi Sami, Alsolami Enad, Sherif Abdalla, Almahdy Mohammed, Elmonier Rady, Alobaidi Waad Y, Akl Ahmed
机构信息
Department of Internal Medicine, University of Jeddah, Jeddah 21493, Saudi Arabia.
Dr. Soliman Fakeeh Hospital, Jeddah 23323, Saudi Arabia.
出版信息
Vaccines (Basel). 2022 Dec 31;11(1):95. doi: 10.3390/vaccines11010095.
OBJECTIVE
Vaccination hesitance for the COVID-19 booster dosage among hemodialysis patients is an important barrier in reducing morbidity and mortality linked to COVID-19 infection. Hence, this study aimed to explore the predictors of the third (booster) dose of COVID-19 vaccine intention among CKD patients on hemodialysis from the Kingdom of Saudi Arabia (KSA).
METHODS
This study was a multi-center cross-sectional study conducted at four dialysis centers in KSA from 13 February 2022 to 21 June 2022. The data was collected by the nephrologist in charge of the unit using a structured study questionnaire, which consisted of four parts; socio-demographic and clinical variables, questions about COVID-19 infection and subjective assessment of health state, COVID-19 booster dose vaccination intention and confidence in vaccines and preferences, and a health belief model. The study population consisted of 179 hemodialysis patients.
RESULTS
Participants in the study had conflicting health beliefs about their vulnerability to COVID-19 infection and the severity of the COVID-19 infection. Study participants expressed positive health beliefs about the advantages of the COVID-19 booster dose, and reported less perceived obstacles in receiving the vaccine. The influence of cues on action among the study population was high. A total of 140 (78.2%) hemodialysis patients expressed their intention to receive the COVID-19 booster dose. Patients who reported poor health in the self-rating of their health status had a substantially higher definite intention to take the COVID-19 booster dose, according to the chi-square test (11.16, df = 3, = 0.01). There was a significant association between the constructs in the HBM model and COVID-19 vaccine (booster) intention. Marital status (OR = 1.67, CI 1.07-2.58) was found to be the strongest predictors of a definite intention to receive a COVID-19 booster dose. Confidence in the locally manufactured vaccine (OR = 0.33, CI 0.17-0.60), education (OR = 0.62, CI 0.41-0.93), and rating of health status (OR = 0.43 CI 0.25-0.74) were the strongest significant correlates of having no definite intention to take the COVID-19 vaccination.
CONCLUSIONS
HBM constructs were found to be significantly associated with vaccination intention, which can be considered while planning policies to promote COVID-19 booster vaccination among hemodialysis patients. The study results could be utilized in drafting policies to improve COVID-19 booster dose vaccination uptake among hemodialysis population.
目的
血液透析患者对新冠病毒加强针疫苗接种的犹豫是降低与新冠病毒感染相关发病率和死亡率的一个重要障碍。因此,本研究旨在探讨沙特阿拉伯王国接受血液透析的慢性肾脏病患者接种第三剂(加强针)新冠病毒疫苗意愿的预测因素。
方法
本研究为多中心横断面研究,于2022年2月13日至2022年6月21日在沙特阿拉伯王国的四个透析中心进行。数据由负责该科室的肾病专家使用结构化研究问卷收集,问卷包括四个部分:社会人口统计学和临床变量、关于新冠病毒感染及健康状况主观评估的问题、新冠病毒加强针疫苗接种意愿及对疫苗的信心和偏好,以及健康信念模型。研究人群包括179名血液透析患者。
结果
研究参与者对自身感染新冠病毒的易感性和新冠病毒感染的严重程度有着相互矛盾的健康信念。研究参与者对新冠病毒加强针的益处表达了积极的健康信念,并报告在接种疫苗时感知到的障碍较少。研究人群中行动线索的影响较高。共有140名(78.2%)血液透析患者表示愿意接种新冠病毒加强针。根据卡方检验(11.16,自由度 = 3,P = 0.01),在自我健康状况评分中报告健康状况较差的患者接种新冠病毒加强针的明确意愿明显更高。健康信念模型中的各因素与新冠病毒疫苗(加强针)接种意愿之间存在显著关联。婚姻状况(比值比 = 1.67,置信区间1.07 - 2.58)被发现是接受新冠病毒加强针明确意愿的最强预测因素。对本地生产疫苗的信心(比值比 = 0.33,置信区间0.17 - 0.60)、教育程度(比值比 = 0.62,置信区间0.41 - 0.93)和健康状况评分(比值比 = 0.43,置信区间0.25 - 0.74)是没有接种新冠病毒疫苗明确意愿的最强显著相关因素。
结论
发现健康信念模型各因素与接种意愿显著相关,在制定促进血液透析患者接种新冠病毒加强针疫苗的政策时可予以考虑。研究结果可用于起草政策,以提高血液透析人群对新冠病毒加强针疫苗的接种率。
相似文献
J Multidiscip Healthc. 2021-5-18
Medicina (Kaunas). 2022-7-21
引用本文的文献
Commun Med (Lond). 2025-4-30
BMC Public Health. 2025-3-18
Vaccines (Basel). 2024-7-19
Hum Vaccin Immunother. 2023-8-1
本文引用的文献
Nat Rev Nephrol. 2022-11
Trop Med Health. 2022-6-30
Front Public Health. 2022
Clin J Am Soc Nephrol. 2022-6